Damora Therapeutics is trading at $21.88, up +5.85%, with healthcare-sector strength the clearest available context for the move.
- No company-specific announcement explaining the October 21, 2026 move surfaced; the latest company release found was an October 2 employee inducement-grant notice.
- Healthcare was up 2.12% amid rotation from technology toward steadier sectors.
- Available evidence supports a sector explanation, not a confirmed company catalyst; supplied broader index gains were below 0.5%.